Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
34.72
+0.05 (0.14%)
At close: Sep 11, 2026, 4:00 PM EDT
33.57
-1.15 (-3.31%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Avalyn Pharma Earnings Call Transcripts
Fiscal Year 2026
-
The company is advancing inhaled therapies for pulmonary fibrosis, aiming to improve tolerability and efficacy over current oral treatments. Key programs are in late-stage clinical trials, with strong long-term data and a robust financial position to support further development and potential market leadership.